Trial Details
RECRUITINGBasic Information
| Clinical ID | c51 |
|---|---|
| Identifier | NCT07265570 |
| Trial Title | Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: ISM5411 tablets|DRUG: ISM5411 tablets|DRUG: ISM5411 tablets|DRUG: Placebo |
Participant Information
| Sponsor | InSilico Medicine Hong Kong Limited |
|---|---|
| City | Beijing Municipality |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-12-10 |
|---|---|
| Primary Completion Date | 2027-08-15 |
| Completion Date | 2027-08-30 |